Prostate Cancer Daily

October 18, 2024

Videos

Peer-to-Peer Clinical Conversations

Novel Epigenomic Liquid Biopsy Detects PSMA Expression in Prostate Cancer - Jacob Berchuck

Jacob Berchuck

Oliver Sartor hosts Jake Berchuck to discuss a novel epigenomic liquid biopsy platform for determining PSMA expression in prostate cancer.

View

Radiation Therapy Options for Localized Prostate Cancer Compared in Major Trial - Jason Efstathiou

Jason Efstathiou

E David Crawford interviews Jason Efstathiou about the PARTIQoL trial, a Phase III study comparing proton beam therapy to IMRT for localized prostate cancer.

View

Beyond the Abstracts

Impact of a Rash Management Guide in Patients Receiving Apalutamide for High-Risk Localized Prostate Cancer in the Apa-RP Study - Beyond the Abstract

Prediction of Undetectable Circulating Tumor DNA by Comprehensive Genomic Profiling Assay in Metastatic Prostate Cancer: The SCRUM-Japan MONSTAR SCREEN Project - Beyond the Abstract

Conference Coverage

ESMO 2024: Invited Discussant: CC-94676-PCA-001 and INSPIRE

ESMO 2024: Invited Discussant: Phase 3 ARANOTE Trial, Phase 3 Evaluation of Transdermal Estradiol Versus LHRH Agonists and Ancillary Study of the PEACE-1

ESMO 2024: RAPSON: Open-Label, Multicenter Randomized Trial of Radium-223 -> Docetaxel Versus Docetaxel -> Radium-223 Sequence in mCRPC with Prospective Biomarker Evaluation

ESMO 2024: INSPIRE: Phase 2 Trial of Nivolumab 3mg/kg and Ipilimumab 1mg/kg in Molecularly Selected Patients with mCRPC

ESMO 2024: Adding Metformin to ADT for Patients with mHSPC: Overall Survival Results from the Multi-Arm, Multi-Stage Randomized Platform Trial STAMPEDE

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management - Beyond the Abstract

Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences.

Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers.

Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer-A pilot study.

Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.

Aerobic Physical Activity and Depression Among Patients With Cancer A Systematic Review and Meta-Analysis

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Prostate Cancer Daily

Prostate Cancer

Login